Investigating the role of MAB_1915 in intrinsic resistance to multiple drugs in Mycobacterium abscessus
- PMID: 39162545
- PMCID: PMC11448072
- DOI: 10.1128/spectrum.03974-23
Investigating the role of MAB_1915 in intrinsic resistance to multiple drugs in Mycobacterium abscessus
Abstract
The increasing clinical significance of Mycobacterium abscessus is owed to its innate high-level, broad-spectrum resistance to antibiotics and therefore rapidly evolves as an important human pathogen. This warrants the identification of novel targets for aiding the discovery of new drugs or drug combinations to treat M. abscessus infections. This study is inspired by the drug-hypersensitive profile of a mutant M. abscessus (U14) with transposon insertion in MAB_1915. We validated the role of MAB_1915 in intrinsic drug resistance in M. abscessus by constructing a selectable marker-free in-frame deletion in MAB_1915 and complementing the mutant with the same or extended version of the gene and then followed by drug susceptibility testing. Judging by the putative function of MAB_1915, cell envelope permeability was studied by ethidium bromide accumulation assay and susceptibility testing against dyes and detergents. In this study, we established genetic evidence of the role of MAB_1915 in intrinsic resistance to rifampicin, rifabutin, linezolid, clarithromycin, vancomycin, and bedaquiline. Disruption of MAB_1915 has also been observed to cause a significant increase in cell envelope permeability in M. abscessus. Restoration of resistance is observed to depend on at least 27 base pairs upstream of the coding DNA sequence of MAB_1915. MAB_1915 could therefore be associated with cell envelope permeability, and hence its role in intrinsic resistance to multiple drugs in M. abscessus, which presents it as a novel target for future development of effective antimicrobials to overcome intrinsic drug resistance in M. abscessus.
Importance: This study reports the role of a putative fadD (MAB_1915) in innate resistance to multiple drugs by M. abscessus, hence identifying MAB_1915 as a valuable target and providing a baseline for further mechanistic studies and development of effective antimicrobials to check the high level of intrinsic resistance in this pathogen.
Keywords: MAB_1915; Mycobacterium abscessus; cell envelope permeability; fatty acid-CoA ligase; intrinsic drug resistance.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




References
-
- Dubois V, Viljoen A, Laencina L, Le Moigne V, Bernut A, Dubar F, Blaise M, Gaillard JL, Guérardel Y, Kremer L, Herrmann JL. 2018. MmpL8MAB controls Mycobacterium abscessus virulence and production of a previously unknown glycolipid family. Proc Natl Acad Sci U S A 115:E10147–56. doi:10.1073/pnas.1812984115 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
- 2021YFA1300900/National Key R&D Program of China
- 81973372,21920102003/MOST | National Natural Science Foundation of China (NSFC)
- 154144KYSB20190005,YJKYYQ20210026/Chinese Academy of Sciences Grants
- 2023YFSY0047/Key R&D Program of Sichuan Province
- SKLRD-OP-202324,SKLRD-Z-202301,SKLRD-OP-202113,SKLRD-Z-202412/State Key Laboratory of Respiratory Disease (SKLRD)
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases